https://www.zacks.com/stock/news/2269028/silgan-slgn-q1-earnings-beat-estimates-revenues-dip-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2269028
May 06, 2024 - Silgan's (SLGN) first-quarter top and bottom lines reflect the impacts of lower volumes owing to customer destocking.
zc:-6118250515002270560
0
https://www.zacks.com/stock/news/2268784/wall-street-analysts-see-a-77-22-upside-in-bicycle-therapeutics-bcyc-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2268784
May 06, 2024 - The average of price targets set by Wall Street analysts indicates a potential upside of 77.2% in Bicycle Therapeutics (BCYC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
zc:3901052620747298667
0
https://www.zacks.com/stock/news/2268786/wall-street-analysts-see-a-56-11-upside-in-pulmonx-lung-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2268786
May 06, 2024 - The consensus price target hints at a 56.1% upside potential for Pulmonx (LUNG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
zc:-4480022124840261860
0
https://seekingalpha.com/news/4100037-btig-sees-murky-road-ahead-for-cannabis-reclassification?source=feed_sector_healthcare
May 04, 2024 - BTIG says the road to reclassifying cannabis as a less dangerous substance remains murky, with the process likely getting bogged down for years by legal delays. Read more here.
0
sa:-5115777029059039122
0
https://seekingalpha.com/news/4099988-gold-down-for-second-straight-week-but-goldman-sees-rebound-later-this-year?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
May 03, 2024 - Gold closes second consecutive weekly loss as investors take profits amid easing Middle East tensions.
0
sa:-3249262212357538806
0
https://www.zacks.com/stock/news/2267876/wall-street-analysts-see-celestica-cls-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2267876
May 03, 2024 - Based on the average brokerage recommendation (ABR), Celestica (CLS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:6317094273666789031
0
https://www.zacks.com/stock/news/2267875/wall-street-analysts-see-zuora-zuo-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2267875
May 03, 2024 - Based on the average brokerage recommendation (ABR), Zuora (ZUO) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-9153036535899522482
0
https://www.zacks.com/stock/news/2267365/sealed-air-see-q1-earnings-top-estimates-increase-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-2267365
May 02, 2024 - Sealed Air (SEE) witnesses year-over-year improvement in its Q1 bottom line reflecting benefits from the cost take-out to grow program.
zc:6693941858180085728
0
https://www.rttnews.com/story.aspx?Id=3444384
May 02, 2024 - Stocks are likely to move to the upside in early trading on Thursday as traders continue to digest yesterday's Federal Reserve announcement. The major index futures are currently pointing to a notably higher open for the markets, with the S&P 500 futures up by 0.8 percent.
0
rttnews:-1935335009414457388
0
https://seekingalpha.com/article/4688328-teck-resources-we-still-see-potential-for-further-gains?source=feed_all_articles
May 01, 2024 - Teck Resources is among the world's most attractive pure-play copper producers and would be a decent acquisition target. Read why TECK stock is a Strong Buy.
0
sa:5447132348294817184
0